Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Effects of Repeated Intra-Silicone Oil Injections of Methotrexate on Proliferative Vitreoretinopathy Grade C: A Multicenter Randomized Controlled Trial Publisher Pubmed



Nourinia R1 ; Safi S2 ; Mohammadpour M1 ; Riaziesfahani H3 ; Ansari Astaneh MR4 ; Falavarjani KG5 ; Ramezani A2, 6, 7 ; Karimi S1, 6, 7, 8 ; Fekri S1, 8 ; Ebrahimiadib N3 ; Khalili Pour E3 ; Nikkhah H1, 6, 7 ; Shoeibi N4 ; Hassanpoor N9 Show All Authors
Authors
  1. Nourinia R1
  2. Safi S2
  3. Mohammadpour M1
  4. Riaziesfahani H3
  5. Ansari Astaneh MR4
  6. Falavarjani KG5
  7. Ramezani A2, 6, 7
  8. Karimi S1, 6, 7, 8
  9. Fekri S1, 8
  10. Ebrahimiadib N3
  11. Khalili Pour E3
  12. Nikkhah H1, 6, 7
  13. Shoeibi N4
  14. Hassanpoor N9
  15. Hosseini M4
  16. Abrishami M4
  17. Abdi F5
  18. Rahimi A11
  19. Jabbarpoor Bonyadi MH12
  20. Moradian S2, 8
  21. Khosravi Mirzaei S1, 13
  22. Safi H1, 6
  23. Anvari P5
  24. Fadakar K3
  25. Mirghorbani M3
  26. Mohammadbagheri N1
  27. Hatami F1, 13
  28. Kheiri B1, 2
  29. Yaseri M14
  30. Khorrami Z2
  31. Ahmadieh H1
Show Affiliations
Authors Affiliations
  1. 1. Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, No. 23, Paidarfard St., Pasdaran Ave., Tehran, 16666, Iran
  2. 2. Ophthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Translational Ophthalmology Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Eye Research Center, The five Senses Health Institute, Moheb Kowsar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Ophthalmology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Department of Ophthalmology, Torfeh Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Labbafinejad Medical Center, Department of Ophthalmology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. Retina & amp
  10. 10. Vitreous Service, Nikookari Eye Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  11. 11. Negah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  12. 12. Hakiman-e Noor Eye Hospital, Tabriz, Iran
  13. 13. Ocular Tissue Engineering Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  14. 14. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Source: Scientific Reports Published:2024


Abstract

In this randomized controlled trial, we assessed the effects of three consecutive intra-silicone oil (SO) injections of methotrexate (MTX) on the outcomes of surgery for proliferative vitreoretinopathy grade C (PVR-C). Seventy-four eyes of 74 patients with PVR-C were included. Of these, 37 eyes were assigned to the MTX group and 37 eyes to the control group. Fourteen patients failed to comply with the 6-month follow-up period. All eyes underwent vitrectomy and SO injection. In the MTX group, 250 µg MTX was injected into the SO after surgery and at weeks 3 and 6 postoperatively. The primary outcome was the retinal reattachment rate at 6 months. The secondary outcomes included limited PVR recurrence and adverse events. Retinal reattachment was achieved in 22 eyes (73.3%) in the MTX group and 23 eyes (76.7%) in the control group (difference: -3.4%, 95% CI: -25.2–18.5%). Limited PVR recurrence was observed in one eye (4.5%) in the MTX group versus nine eyes (39.1%) in the control group at 6 months (P = 0.01). No adverse effects were observed. Adjunctive treatment with three consecutive applications of intra-SO MTX did not reveal a significant effect on the retinal re-detachment rate but could statistically significantly reduce limited PVR recurrence. Trial registration: http//ClinicalTrials.gov NCT04482543, 22/07/2020. © The Author(s) 2024.
Related Docs
1. Intravitreal Methotrexate, Journal of Ophthalmic and Vision Research (2021)
Experts (# of related papers)